Atherosclerosis, gut microbiome, and exercise in a meta-omics perspective: a literature review

Haotian Tang1, Yanqing Huang1, Didi Yuan1

  • 1Department of Histology and Embryology, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.

Peerj
|April 8, 2024
PubMed

Insights

Exercise impacts atherosclerosis by altering the gut microbiome. Meta-omics techniques like metagenomics and metabolomics reveal these connections, offering new avenues for cardiovascular disease prevention and treatment.

Area of Science:

  • Cardiovascular Health
  • Microbiome Research
  • Exercise Science

Background:

  • Cardiovascular diseases are a leading global cause of mortality, with atherosclerosis being a primary driver.
  • The gut microbiome's composition and function are intricately linked to atherosclerosis development.
  • Exercise interventions show potential for modulating the gut microbiome and mitigating cardiovascular risk.

Approach:

  • A comprehensive literature review was performed using PubMed and Web of Science.
  • The review focused on meta-omics techniques, specifically metagenomics and metabolomics.
  • The study investigated the impact of exercise interventions on the gut microbiome and its relationship with atherosclerosis.

Key Points:

  • Meta-omics technologies provide deep insights into the interplay between exercise, the gut microbiome, metabolome, and cardiometabolic health.
  • Metagenomics identifies microbial shifts post-exercise, while metabolomics reveals associated metabolic changes.
  • These integrated approaches elucidate mechanisms by which exercise influences atherosclerosis.

Conclusions:

  • Exercise plays a significant role in atherosclerosis, with the gut microbiome acting as a key mediator.
  • Meta-omics offers powerful tools for microbiome research, but methodological advancements are needed.
  • Further large-scale cohort studies are crucial to fully understand the complex interrelationships involved.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...